VAERS reports by lot

Merck Pneumococcal lot W021636: VAERS reports

37 VAERS reports list lot W021636 as a Merck Pneumococcal vaccine, received between 2022-10-19 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
37
Reports
0%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1841%
Dermatological (non-injection-site)818%
Allergic / Anaphylactic614%
General / Systemic (non-local)511%
Neurological25%
Gastrointestinal25%
Musculoskeletal25%
Cardiac / Cardiovascular12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas3
Michigan3
California3
Georgia3
Virginia2
Maryland2
New York2
Tennessee2
Oklahoma2
Florida1
Washington1
Louisiana1

Reports by month received

2022-101
2022-113
2022-121
2023-011
2023-021
2023-032
2023-042
2023-051
2023-062
2023-091
2023-1010
2023-115
2023-125
2024-011
2024-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.